the potential difference in survival and antitumor effect due to different dosage schedules of cyclophosphamide ( cpm ) treatment was analyzed in a/j mice inoculated with mouse neuroblastoma c 1300 cells , which closely resembles the human neuroblastoma in its capacity of cathecolamin secretion and in response to chemotherapy .
C0010583
cyclophosphamide
C0027819
neuroblastoma